tiprankstipranks
Trending News
More News >

SynAct Pharma to Host Capital Markets Day in Stockholm

Story Highlights
SynAct Pharma to Host Capital Markets Day in Stockholm

Confident Investing Starts Here:

SynAct Pharma AB ( (SE:SYNACT) ) has shared an announcement.

SynAct Pharma AB is inviting investors, analysts, and media to its Capital Markets Day on June 4, 2025, in Stockholm. The event will provide updates on the company’s Phase 2b ADVANCE study for rheumatoid arthritis and plans to expand the use of resomelagon into other indications, highlighting SynAct’s strategic efforts to enhance its market positioning in the biotechnology sector.

More about SynAct Pharma AB

SynAct Pharma AB is a clinical-stage biotechnology company focused on resolving inflammation through selective activation of the melanocortin system. The company is actively involved in developing treatments for inflammatory and autoimmune diseases, with a particular emphasis on rheumatoid arthritis.

Average Trading Volume: 205,175

Current Market Cap: SEK756.7M

For an in-depth examination of SYNACT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App